Evidence map›Paper›PMID 27601667›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

WD40 domain of Apc1 is critical for the coactivator-induced allosteric transition that stimulates APC/C catalytic activity.

Qiuhong Li, Leifu Chang, Shintaro Aibara, Jing Yang, Ziguo Zhang, David Barford

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Examining the mechanistic relationship of APC/CProtein science : a publication of the Protein Society · 2022
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Qiuhong LiMedical Research Council Laboratory of Molecular Biology, Cambridge CB2 0QH, United Kingdom; Section of Structural Biology, Chester Beatty Laboratories, Institute of Cancer Research, London SW3 6JB, United Kingdom.
Leifu ChangMedical Research Council Laboratory of Molecular Biology, Cambridge CB2 0QH, United Kingdom;
Shintaro AibaraMedical Research Council Laboratory of Molecular Biology, Cambridge CB2 0QH, United Kingdom;
Jing YangMedical Research Council Laboratory of Molecular Biology, Cambridge CB2 0QH, United Kingdom;
Ziguo ZhangMedical Research Council Laboratory of Molecular Biology, Cambridge CB2 0QH, United Kingdom;
David BarfordMedical Research Council Laboratory of Molecular Biology, Cambridge CB2 0QH, United Kingdom; dbarford@mrc-lmb.cam.ac.uk.
Medical Research Council · GBMRC Laboratory of Molecular Biology · GB

Funding

Cancer Research UK 14109Medical Research Council MC_U105178939Medical Research Council MC_UP_1201/6
6 · The paper itself

Abstract

The anaphase-promoting complex/cyclosome (APC/C) is a large multimeric cullin-RING E3 ubiquitin ligase that orchestrates cell-cycle progression by targeting cell-cycle regulatory proteins for destruction via the ubiquitin proteasome system. The APC/C assembly comprises two scaffolding subcomplexes: the platform and the TPR lobe that together coordinate the juxtaposition of the catalytic and substrate-recognition modules. The platform comprises APC/C subunits Apc1, Apc4, Apc5, and Apc15. Although the role of Apc1 as an APC/C scaffolding subunit has been characterized, its specific functions in contributing toward APC/C catalytic activity are not fully understood. Here, we report the crystal structure of the N-terminal domain of human Apc1 (Apc1N) determined at 2.2-Å resolution and provide an atomic-resolution description of the architecture of its WD40 (WD40 repeat) domain (Apc1(WD40)). To understand how Apc1(WD40) contributes to APC/C activity, a mutant form of the APC/C with Apc1(WD40) deleted was generated and evaluated biochemically and structurally. We found that the deletion of Apc1(WD40) abolished the UbcH10-dependent ubiquitination of APC/C substrates without impairing the Ube2S-dependent ubiquitin chain elongation activity. A cryo-EM structure of an APC/C-Cdh1 complex with Apc1(WD40) deleted showed that the mutant APC/C is locked into an inactive conformation in which the UbcH10-binding site of the catalytic module is inaccessible. Additionally, an EM density for Apc15 is not visible. Our data show that Apc1(WD40) is required to mediate the coactivator-induced conformational change of the APC/C that is responsible for stimulating APC/C catalytic activity by promoting UbcH10 binding. In contrast, Ube2S activity toward APC/C substrates is not dependent on the initiation-competent conformation of the APC/C.

Indexed as

Allosteric RegulationAnaphase-Promoting Complex-CyclosomeAntigens, CDApc1 Subunit, Anaphase-Promoting Complex-CyclosomeBinding SitesCadherinsCell Cycle ProteinsCrystallography, X-RayHumansMutant ProteinsProtein BindingProtein ConformationProtein DomainsUbiquitinUbiquitinationUbiquitin-Conjugating EnzymesANAPC15 protein, humanANAPC1 protein, humanAnaphase-Promoting Complex-CyclosomeAntigens, CDApc1 Subunit, Anaphase-Promoting Complex-CyclosomeCadherinsCDH1 protein, humanCell Cycle ProteinsCULL-RING ligase, humanMutant ProteinsUBE2C protein, humanUbe2S protein, humanUbiquitinUbiquitin-Conjugating EnzymesUbiquitin-Protein LigasesAPC/Ccell cycleUbcH10Ube2Subiquitination

Identifiers

PMID27601667
PMCPMC5035875
OpenAlexW2516173312

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.